Delivery Order SPE2DB20D1100-SPE2DB24FC7E9
Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $2.8K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4565978330 - Norepinephrine 8 mg/250 ml-D5W 250ml. The firm-fixed-price delivery order, valued at $1,686.36, has an ultimate completion date of October 1, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of norepinephrine 4 ml 10s. The contract is a delivery order valued at $1,318.38 with a firm fixed price and an ultimate completion date of January 8, 2024. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,017,672 units of the drug Norepinephrine 8 mg/250 mL-D5W 250 mL. The contract has a ceiling value of $1,009.65 and is a firm fixed-price delivery order with a period of performance through January 24, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,759.11, is for the delivery of a 250 mL bag of norepinephrine 8 mg/250 mL in D5W. This is a firm fixed-price delivery order contract with a completion date of January 23, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This federal contract award, with the ID SPE2DB22D3501|SPE2DB24FWV06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4565644183 - Norepinephrine 8 mg/250 ml-D5W 250ml. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,927.88 and an ultimate completion date of September 3, 2024. This award is not associated with any set-aside designation. AmerisourceBergen, through its Corporate...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. The $1,606.80 firm fixed price contract is for the supply of 4564414423 - Norepinephrine 8 mg/250 ml-D5W 250 ml, with a completion date of April 29, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the...
- This federal contract award, valued at $1,065.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Norepinephrine 4 mg/250 mL-D5W, a critical care medication, to support military treatment facilities and other government healthcare providers. This delivery order contract is a firm fixed-price agreement, with an ultimate completion date of August 13, 2024. Amerisourcebergen holds several...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,107.11 firm fixed-price delivery order is for the supply of 4 mg/4 mL vials of the drug norepinephrine. The award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,325.44 firm fixed-price delivery order is for the supply of 4,568,004,494 units of 4 mg/4 ml vials of the drug norepinephrine. The contract has an ultimate completion date of April 24, 2025 and was awarded on April 23, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the supply of Norepinephrine 4 mg/4 ml vials. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $3,578.89, and has a completion date of May 28, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, worth up to...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB24FC7E9Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of norepinephrine 8 mg/250 ml-D5W 250ml. The contract, valued at $2,796.06, is a firm fixed-price delivery order with a completion date of July 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.
Generated 10/11/24, 9:11 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/12/24 |